{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T21:04:30Z","timestamp":1775077470612,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11436-3","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:28:49Z","timestamp":1768314529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular signatures of hypertension in polycystic ovary syndrome: Endothelin-1 and CYP11A1 as biomarkers of vascular and metabolic dysfunction"],"prefix":"10.1007","volume":"53","author":[{"given":"Mohammed-Ridha","family":"Hosein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8219-1001","authenticated-orcid":false,"given":"Zjwan","family":"Housein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"issue":"7","key":"11436_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073789","volume":"22","author":"E Rudnicka","year":"2021","unstructured":"Rudnicka E, Suchta K, Grymowicz M, Calik-Ksepka A, Smolarczyk K, Duszewska AM, Smolarczyk R, Meczekalski B (2021) Chronic low grade inflammation in pathogenesis of PCOS. Int J Mol Sci 22(7):3789. https:\/\/doi.org\/10.3390\/ijms22073789","journal-title":"Int J Mol Sci"},{"issue":"11","key":"11436_CR2","doi-asserted-by":"publisher","first-page":"10689","DOI":"10.1007\/s11033-022-07695-5","volume":"49","author":"M Shamsi","year":"2022","unstructured":"Shamsi M, Ghazavi A, Saeedifar AM, Mosayebi G, Pour SK, Ganji A (2022) The immune system\u2019s role in PCOS. Mol Biol Rep 49(11):10689\u201310702. https:\/\/doi.org\/10.1007\/s11033-022-07695-5","journal-title":"Mol Biol Rep"},{"issue":"1","key":"11436_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00511-3","volume":"10","author":"E Stener-Victorin","year":"2024","unstructured":"Stener-Victorin E, Teede H, Norman RJ, Legro R, Goodarzi MO, Dokras A, Laven J, Hoeger K, Piltonen TT (2024) Polycystic ovary syndrome. Nat Rev Dis Primers 10(1):27. https:\/\/doi.org\/10.1038\/s41572-024-00511-3","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"11436_CR4","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/humupd\/dmy022","volume":"24","author":"MA Skiba","year":"2018","unstructured":"Skiba MA, Islam RM, Bell RJ, Davis SR (2018) Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 24(6):694\u2013709. https:\/\/doi.org\/10.1093\/humupd\/dmy022","journal-title":"Hum Reprod Update"},{"issue":"7","key":"11436_CR5","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1210\/clinem\/dgae917","volume":"110","author":"M Amiri","year":"2025","unstructured":"Amiri M, Hatoum S, Buyalos RP, Sheidaei A, Azziz R (2025) The influence of study quality, age, and geographic factors on PCOS prevalence-a systematic review and meta-analysis. J Clin Endocrinol Metab 110(7):2082\u20132103. https:\/\/doi.org\/10.1210\/clinem\/dgae917","journal-title":"J Clin Endocrinol Metab"},{"key":"11436_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.coemr.2020.03.004","volume":"12","author":"S Mumusoglu","year":"2020","unstructured":"Mumusoglu S, Yildiz BO (2020) Polycystic ovary syndrome phenotypes and prevalence: differential impact of diagnostic criteria and clinical versus unselected population. Curr Opin Endocr Metab Res 12:66\u201371. https:\/\/doi.org\/10.1016\/j.coemr.2020.03.004","journal-title":"Curr Opin Endocr Metab Res"},{"key":"11436_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.614679","volume":"12","author":"F Duic\u0103","year":"2021","unstructured":"Duic\u0103 F, D\u0103nil\u0103 CA, Boboc AE, Antoniadis P, Condrat CE, Onciul S, Suciu N, Cre\u0163oiu SM, Varlas VN, Cre\u0163oiu D (2021) Impact of increased oxidative stress on cardiovascular diseases in women with polycystic ovary syndrome. Front Endocrinol 12:614679. https:\/\/doi.org\/10.3389\/fendo.2021.614679","journal-title":"Front Endocrinol"},{"issue":"2","key":"11436_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/genes13020302","volume":"13","author":"R Heidarzadehpilehrood","year":"2022","unstructured":"Heidarzadehpilehrood R, Pirhoushiaran M, Abdollahzadeh R, Binti Osma M, Sakinah M, Nordin N, Abdul Hamid H (2022) A review on CYP11A1, CYP17A1, and CYP19A1 polymorphism studies: candidate susceptibility genes for polycystic ovary syndrome (PCOS) and infertility. Genes 13(2):302. https:\/\/doi.org\/10.3390\/genes13020302","journal-title":"Genes"},{"issue":"1","key":"11436_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43042-019-0031-4","volume":"20","author":"S Ashraf","year":"2019","unstructured":"Ashraf S, Nabi M, Rashid F, Amin S (2019) Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review. Egypt J Med Hum Genet 20(1):1\u201310. https:\/\/doi.org\/10.1186\/s43042-019-0031-4","journal-title":"Egypt J Med Hum Genet"},{"issue":"2","key":"11436_CR10","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1007\/s12020-024-04065-y","volume":"87","author":"G Wazir","year":"2025","unstructured":"Wazir G, Wajid A, Wahid A, Batool A, Parveen A, Maqsood Q, Zahid A, Aslam S, Malkani N (2025) Genomic association of SNPs rs4077582 of CYP11A1 and rs700519 of CYP19A1 genes with polycystic ovarian syndrome. Endocrine 87(2):850\u2013856. https:\/\/doi.org\/10.1007\/s12020-024-04065-y","journal-title":"Endocrine"},{"key":"11436_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.889029","volume":"13","author":"Q Wang","year":"2022","unstructured":"Wang Q, Wang H, Li P, Li X, Wang Z, Yan L, Shi Y (2022) Association of polycystic ovary syndrome phenotypes with adverse pregnancy outcomes after in-vitro fertilization\/intracytoplasmic sperm injection. Front Endocrinol 13:889029. https:\/\/doi.org\/10.3389\/fendo.2022.889029","journal-title":"Front Endocrinol"},{"issue":"9","key":"11436_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/biom11091350","volume":"11","author":"S Pandurevic","year":"2021","unstructured":"Pandurevic S, Macut D, Fanelli F, Pagotto U, Gambineri A (2021) Biomediators in polycystic ovary syndrome and cardiovascular risk. Biomolecules 11(9):1350. https:\/\/doi.org\/10.3390\/biom11091350","journal-title":"Biomolecules"},{"key":"11436_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.metabol.2017.09.016","volume":"86","author":"P Anagnostis","year":"2018","unstructured":"Anagnostis P, Tarlatzis BC, Kauffman RP (2018) Polycystic ovarian syndrome (PCOS): long-term metabolic consequences. Metabolism 86:33\u201343. https:\/\/doi.org\/10.1016\/j.metabol.2017.09.016","journal-title":"Metabolism"},{"issue":"5","key":"11436_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19053089","volume":"19","author":"A Szeliga","year":"2022","unstructured":"Szeliga A, Rudnicka E, Maciejewska-Jeske M, Kucharski M, Kostrzak A, Hajbos M, Niwczyk O, Smolarczyk R, Meczekalski B (2022) Neuroendocrine determinants of polycystic ovary syndrome. Int J Environ Res Public Health 19(5):3089. https:\/\/doi.org\/10.3390\/ijerph19053089","journal-title":"Int J Environ Res Public Health"},{"issue":"8","key":"11436_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/jne.70028","volume":"37","author":"AM Moore","year":"2025","unstructured":"Moore AM (2025) Neuroendocrine mechanisms responsible for elevated gonadotrophin-releasing hormone and luteinising hormone pulses in polycystic ovary syndrome. J Neuroendocrinol 37(8):e70028. https:\/\/doi.org\/10.1111\/jne.70028","journal-title":"J Neuroendocrinol"},{"key":"11436_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.815968","volume":"13","author":"B Liao","year":"2022","unstructured":"Liao B, Qi X, Yun C, Qiao J, Pang Y (2022) Effects of androgen excess-related metabolic disturbances on granulosa cell function and follicular development. Front Endocrinol 13:815968. https:\/\/doi.org\/10.3389\/fendo.2022.815968","journal-title":"Front Endocrinol"},{"key":"11436_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.741764","volume":"12","author":"H Ding","year":"2021","unstructured":"Ding H, Zhang J, Zhang F, Zhang S, Chen X, Liang W, Xie Q (2021) Resistance to the insulin and elevated level of androgen: a major cause of polycystic ovary syndrome. Front Endocrinol 12:741764. https:\/\/doi.org\/10.3389\/fendo.2021.741764","journal-title":"Front Endocrinol"},{"issue":"8","key":"11436_CR18","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.3390\/ijms23084110","volume":"23","author":"D Armanini","year":"2022","unstructured":"Armanini D, Boscaro M, Bordin L, Sabbadin C (2022) Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism. Int J Mol Sci 23(8):4110. https:\/\/doi.org\/10.3390\/ijms23084110","journal-title":"Int J Mol Sci"},{"issue":"3","key":"11436_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/03000605231164548","volume":"51","author":"CE Kosmas","year":"2023","unstructured":"Kosmas CE, Bousvarou MD, Kostara CE, Papakonstantinou EJ, Salamou E, Guzman E (2023) Insulin resistance and cardiovascular disease. J Int Med Res 51(3):3000605231164548. https:\/\/doi.org\/10.1177\/03000605231164548","journal-title":"J Int Med Res"},{"issue":"6","key":"11436_CR20","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s11886-024-02050-5","volume":"26","author":"P Dubey","year":"2024","unstructured":"Dubey P, Reddy S, Sharma K, Johnson S, Hardy G, Dwivedi AK (2024) Polycystic ovary syndrome, insulin resistance, and cardiovascular disease. Curr Cardiol Rep 26(6):483\u2013495. https:\/\/doi.org\/10.1007\/s11886-024-02050-5","journal-title":"Curr Cardiol Rep"},{"key":"11436_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2024.10034321","volume":"25","author":"R Heidarzadehpilehrood","year":"2024","unstructured":"Heidarzadehpilehrood R, Hamid HA, Pirhoushiaran M (2024) Vitamin D receptor (VDR) gene polymorphisms and risk for polycystic ovary syndrome and infertility: an updated systematic review and meta-analysis. Metab Open 25:100343. https:\/\/doi.org\/10.1016\/j.metop.2024.10034321","journal-title":"Metab Open"},{"issue":"3","key":"11436_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2024.103129","volume":"56","author":"R Heidarzadehpilehrood","year":"2025","unstructured":"Heidarzadehpilehrood R, Pirhoushiaran M, Osman MB, Ling KH, Hamid HA (2025) Identifying genetic profiles in peripheral blood mononuclear cells in women with polycystic ovary syndrome: an observational case-control study. Arch Med Res 56(3):103129. https:\/\/doi.org\/10.1016\/j.arcmed.2024.103129","journal-title":"Arch Med Res"},{"issue":"2","key":"11436_CR23","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ncrna.2024.01.002","volume":"9","author":"R Heidarzadehpilehrood","year":"2024","unstructured":"Heidarzadehpilehrood R, Pirhoushiaran M (2024) Biomarker potential of competing endogenous RNA networks in polycystic ovary syndrome (PCOS). Non-coding RNA Res 9(2):624\u2013640. https:\/\/doi.org\/10.1016\/j.ncrna.2024.01.002","journal-title":"Non-coding RNA Res"},{"issue":"2","key":"11436_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11020518","volume":"11","author":"R Heidarzadehpilehrood","year":"2023","unstructured":"Heidarzadehpilehrood R, Pirhoushiaran M, Binti Osman M, Abdul Hamid H, Ling KH (2023) Weighted gene co-expression network analysis (WGCNA) discovered novel long non-coding RNAs for polycystic ovary syndrome. Biomedicines 11(2):518. https:\/\/doi.org\/10.3390\/biomedicines11020518","journal-title":"Biomedicines"},{"issue":"1","key":"11436_CR25","doi-asserted-by":"publisher","DOI":"10.5812\/ijpr-139985","volume":"22","author":"R Heidarzadehpilehrood","year":"2023","unstructured":"Heidarzadehpilehrood R, Pirhoushiaran M, Binti Osman M, Ling KH, Abdul Hamid H (2023) Unveiling key biomarkers and therapeutic drugs in polycystic ovary syndrome (PCOS) through pathway enrichment analysis and hub gene-miRNA networks. Iran J Pharm Res 22(1):e139985. https:\/\/doi.org\/10.5812\/ijpr-139985","journal-title":"Iran J Pharm Res"},{"issue":"8","key":"11436_CR26","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/10641963.2020.1772815","volume":"42","author":"S \u00d6zkan","year":"2020","unstructured":"\u00d6zkan S, Y\u0131lmaz \u00d6\u00c7, Yavuz B (2020) Increased masked hypertension prevalence in patients with polycystic ovary syndrome (PCOS). Clin Experimental Hypertens (New York N Y : 1993) 42(8):681\u2013684. https:\/\/doi.org\/10.1080\/10641963.2020.1772815","journal-title":"Clin Experimental Hypertens (New York N Y : 1993)"},{"key":"11436_CR27","doi-asserted-by":"publisher","DOI":"10.1071\/RD24158","volume":"37","author":"M Szymanska","year":"2024","unstructured":"Szymanska M, Basavaraja R, Meidan R (2024) A tale of two endothelins: the rise and fall of the corpus luteum. Reprod Fertil Dev 37:RD24158. https:\/\/doi.org\/10.1071\/RD24158","journal-title":"Reprod Fertil Dev"},{"key":"11436_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.atherosclerosis.2019.11.001","volume":"292","author":"RM Gupta","year":"2020","unstructured":"Gupta RM, Libby P, Barton M (2020) Linking regulation of nitric oxide to endothelin-1: the yin and yang of vascular tone in the atherosclerotic plaque. Atherosclerosis 292:201\u2013203. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.11.001","journal-title":"Atherosclerosis"},{"issue":"5","key":"11436_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.52586\/4926","volume":"26","author":"A Pautz","year":"2021","unstructured":"Pautz A, Li H, Kleinert H (2021) Regulation of NOS expression in vascular diseases. Front Bioscience (Landmark edition) 26(5):85\u2013101. https:\/\/doi.org\/10.52586\/4926","journal-title":"Front Bioscience (Landmark edition)"},{"issue":"11","key":"11436_CR30","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1113\/JP277756","volume":"597","author":"CW Usselman","year":"2019","unstructured":"Usselman CW, Yarovinsky TO, Steele FE, Leone CA, Taylor HS, Bender JR, Stachenfeld NS (2019) Androgens drive microvascular endothelial dysfunction in women with polycystic ovary syndrome: role of the endothelin B receptor. J Physiol 597(11):2853\u20132865. https:\/\/doi.org\/10.1113\/JP277756","journal-title":"J Physiol"},{"issue":"2","key":"11436_CR31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1530\/EC-20-0527","volume":"10","author":"JR Mellembakken","year":"2021","unstructured":"Mellembakken JR, Mahmoudan A, M\u00f8rkrid L, Sundstr\u00f6m-Poromaa I, Morin-Papunen L, Tapanainen JS, Piltonen TT, Hirschberg AL, Stener-Victorin E, Vanky E, Ravn P, Jensen RC, Andersen MS, Glintborg D (2021) Higher blood pressure in normal weight women with PCOS compared to controls. Endocr Connect 10(2):154\u2013163. https:\/\/doi.org\/10.1530\/EC-20-0527","journal-title":"Endocr Connect"},{"issue":"2","key":"11436_CR32","first-page":"153","volume":"15","author":"N Tran","year":"2022","unstructured":"Tran N, Garcia T, Aniqa M, Ali S, Ally A, Nauli SM (2022) Endothelial nitric oxide synthase (eNOS) and the cardiovascular system: in physiology and in disease states. Am J Biomed Sci Res 15(2):153\u2013177","journal-title":"Am J Biomed Sci Res"},{"issue":"2","key":"11436_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4149\/gpb_2022060","volume":"42","author":"A Sydorchuk","year":"2023","unstructured":"Sydorchuk A, Sydorchuk L, Gutnitska A, Vasyuk V, Tkachuk O, Dzhuryak V, Myshkovskii Y, Kyfiak P, Sydorchuk R, Iftoda O (2023) The role of NOS3 (rs2070744) and GNB3 (rs5443) genes\u2019 polymorphisms in endothelial dysfunction pathway and carotid intima-media thickness in hypertensive patients. Gen Physiol Biophys 42(2):179\u2013190. https:\/\/doi.org\/10.4149\/gpb_2022060","journal-title":"Gen Physiol Biophys"},{"issue":"9","key":"11436_CR34","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3390\/life11090986","volume":"11","author":"K Kostov","year":"2021","unstructured":"Kostov K (2021) The causal relationship between Endothelin-1 and hypertension: focusing on endothelial dysfunction, arterial stiffness, vascular remodeling, and blood pressure regulation. Life (Basel Switzerland) 11(9):986. https:\/\/doi.org\/10.3390\/life11090986","journal-title":"Life (Basel Switzerland)"},{"issue":"2","key":"11436_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.33263\/BRIAC132.123","volume":"13","author":"A Sydorchuk","year":"2023","unstructured":"Sydorchuk A, Sydorchuk L, Gutnitska A, Margaryan A, Dzhuryak V, Sydorchuk R, Iftoda O (2023) Linkage of metabolic disorders, endothelial dysfunction and NOS3 (rs2070744) and GNB3 (rs5443) genes polymorphisms in hypertensive patients. Biointerface Res Appl Chem Open-Access J 13(2):1\u201312. https:\/\/doi.org\/10.33263\/BRIAC132.123","journal-title":"Biointerface Res Appl Chem Open-Access J"},{"issue":"23","key":"11436_CR36","doi-asserted-by":"publisher","first-page":"14663","DOI":"10.3390\/ijms232314663","volume":"23","author":"D Szukiewicz","year":"2022","unstructured":"Szukiewicz D, Trojanowski S, Kociszewska A, Szewczyk G (2022) Modulation of the inflammatory response in polycystic ovary syndrome (PCOS)-searching for epigenetic factors. Int J Mol Sci 23(23):14663. https:\/\/doi.org\/10.3390\/ijms232314663","journal-title":"Int J Mol Sci"},{"issue":"3","key":"11436_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18030980","volume":"18","author":"MC Budani","year":"2021","unstructured":"Budani MC, Tiboni GM (2021) Novel insights on the role of nitric oxide in the ovary: a review of the literature. Int J Environ Res Public Health 18(3):980. https:\/\/doi.org\/10.3390\/ijerph18030980","journal-title":"Int J Environ Res Public Health"},{"issue":"10","key":"11436_CR38","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.70958","volume":"16","author":"GD Brice\u00f1o Silva","year":"2024","unstructured":"Brice\u00f1o Silva GD, Thomas Garcia KD, Ajamyan H, Shekhawat P, Rodriguez LC, Hammoud A, Avalos Zapata MJ, Flores Hernandez N, Rayon Rayon HM (2024) Polycystic ovarian syndrome: exploring hypertension and cardiometabolic implications. Cureus 16(10):e70958. https:\/\/doi.org\/10.7759\/cureus.70958","journal-title":"Cureus"},{"issue":"1","key":"11436_CR39","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s12884-021-03957-5","volume":"21","author":"N Emami","year":"2021","unstructured":"Emami N, Moini A, Yaghmaei P, Akbarinejad V, Shahhoseini M, Alizadeh A (2021) Differences in expression of genes related to steroidgenesis in abdominal subcutaneous adipose tissue of pregnant women with and without PCOS; a case control study. BMC Pregnancy Childbirth 21(1):490. https:\/\/doi.org\/10.1186\/s12884-021-03957-5","journal-title":"BMC Pregnancy Childbirth"},{"key":"11436_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7624932","volume":"2018","author":"R Dadachanji","year":"2018","unstructured":"Dadachanji R, Shaikh N, Mukherjee S (2018) Genetic variants associated with hyperandrogenemia in PCOS pathophysiology. Genet Res Int 2018:7624932. https:\/\/doi.org\/10.1155\/2018\/7624932","journal-title":"Genet Res Int"},{"key":"11436_CR41","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","volume":"502","author":"X Zeng","year":"2020","unstructured":"Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC (2020) Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta 502:214\u2013221. https:\/\/doi.org\/10.1016\/j.cca.2019.11.003","journal-title":"Clin Chim Acta"},{"issue":"11","key":"11436_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60111821","volume":"60","author":"E Longhitano","year":"2024","unstructured":"Longhitano E, Calabrese V, Casuscelli C, Di Carlo S, Maltese S, Romeo A, Calanna M, Conti G, Santoro D (2024) Proteinuria and progression of renal damage: the main pathogenetic mechanisms and pharmacological approach. Medicina (Kaunas, Lithuania) 60(11):1821. https:\/\/doi.org\/10.3390\/medicina60111821","journal-title":"Medicina (Kaunas, Lithuania)"},{"issue":"1","key":"11436_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.14740\/jem716","volume":"11","author":"MS Morshed","year":"2021","unstructured":"Morshed MS, Banu H, Akhtar N, Sultana T, Begum A, Zamilla M, Hasanat MA (2021) Luteinizing hormone to follicle-stimulating hormone ratio significantly correlates with androgen level and manifestations are more frequent with hyperandrogenemia in women with polycystic ovary syndrome. J Endocrinol Metab 11(1):14\u201321. https:\/\/doi.org\/10.14740\/jem716","journal-title":"J Endocrinol Metab"},{"issue":"1","key":"11436_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-023-01159-6","volume":"21","author":"AO Awonuga","year":"2023","unstructured":"Awonuga AO, Camp OG, Abu-Soud HM (2023) A review of nitric oxide and oxidative stress in typical ovulatory women and in the pathogenesis of ovulatory dysfunction in PCOS. Reprod Biol Endocrinol 21(1):111. https:\/\/doi.org\/10.1186\/s12958-023-01159-6","journal-title":"Reprod Biol Endocrinol"},{"issue":"9","key":"11436_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10092124","volume":"10","author":"CV Suschek","year":"2022","unstructured":"Suschek CV, Feibel D, von Kohout M, Opl\u00e4nder C (2022) Enhancement of nitric oxide bioavailability by modulation of cutaneous nitric oxide stores. Biomedicines 10(9):2124. https:\/\/doi.org\/10.3390\/biomedicines10092124","journal-title":"Biomedicines"},{"key":"11436_CR46","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.lfs.2019.04.046","volume":"228","author":"Y Li","year":"2019","unstructured":"Li Y, Chen C, Ma Y, Xiao J, Luo G, Li Y, Wu D (2019) Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS). Life Sci 228:167\u2013175. https:\/\/doi.org\/10.1016\/j.lfs.2019.04.046","journal-title":"Life Sci"},{"issue":"6","key":"11436_CR47","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.fertnstert.2025.01.006","volume":"123","author":"A Wang","year":"2025","unstructured":"Wang A, Corley J, Jaswa EG, Lin J, Smith DL, McCulloch CE, Huddleston H, Cedars MI (2025) Association of polycystic ovary syndrome with endothelial health, cardiovascular risk, and cellular aging. Fertil Steril 123(6):1123\u20131132. https:\/\/doi.org\/10.1016\/j.fertnstert.2025.01.006","journal-title":"Fertil Steril"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11436-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11436-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11436-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T03:02:11Z","timestamp":1768359731000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11436-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11436"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11436-3","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"12 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"284"}}